Saturday, July 11, 2026

pharma · Neoplasms,Non-Small Cell Lung Cancer

Tianjin Hemay Pharmaceutical

Tianjin Hemay Pharmaceutical trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
2
Patents
0
Intelligence · Clinical Trials

Tianjin Hemay Pharmaceutical clinical trials

Registry index of 1 ClinicalTrials.gov studies linked to Tianjin Hemay Pharmaceutical programs — each row shows trial ID, program name, phase, status, and indication.

Tianjin Hemay Pharmaceutical trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

1 updates

Latest clinical program signals indexed for Tianjin Hemay Pharmaceutical.

  1. Hemay020 — Phase 1

    Clinical update

Trial registry

1 studies